Lv1
24 积分 2024-01-24 加入
Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis
19小时前
待确认
Psoriasis
20小时前
已完结
Brain metastases and mortality in patients with ALK + metastatic non-small cell lung cancer treated with second-generation ALK tyrosine kinase inhibitors as first-line targeted therapies: An observational cohort study
1个月前
已完结
Amivantamab plus Lazertinib in Previously Untreated EGFR -Mutated Advanced NSCLC
1个月前
已完结
FLAIR: A Phase II, Open label, Randomized Study of Osimertinib Plus Bevacizumab versus Osimertinib in Recurrent or Metastatic Treatment-naïve NSCLC Patients Harboring EGFR 21L858R Mutation
2个月前
已完结
Comparison of clinical outcome of patients with non-small-cell lung cancer harbouring epidermal growth factor receptor exon 19 or exon 21 mutations
2个月前
已完结
Osimertinib with or without Chemotherapy in EGFR -Mutated Advanced NSCLC
2个月前
已完结
The changing treatment landscape of EGFR-mutant non-small-cell lung cancer
2个月前
已完结
Chapter 44 - Role of the pharmacist in research
2个月前
已关闭
Durvalumab plus paclitaxel/carboplatin plus bevacizumab followed by durvalumab, bevacizumab plus olaparib maintenance among patients with newly-diagnosed advanced ovarian cancer without a tumor BRCA1/BRCA2 mutation: Updated results from DUO-O/ENGOT-OV46/GOG-3025 Trial
4个月前
已完结
皖公网安备34019202002308
